MedTrace Logo

Comparative Clinical Trial of Lornoxicam to Diclofenac in Patients of Osteoarthritis of Knee Joint.

NCT01055470 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-01-25

No results posted yet for this study

Summary

The purpose of this study was to compare the pain relieving action of the lornoxicam and diclofenac in patients of OA knee.

Conditions

  • Osteoarthritis of Knee Joint

Interventions

DRUG

Diclofenac

Tab. Diclofenac 50 mg 12 hrly, orally, in morning and in evening after taking food for 3 months.

DRUG

Lornoxicam

Tab. Lornoxicam 4 mg , orally, 8 hourly after taking food in morning , in noon and evening for 3 months.

Sponsors & Collaborators

  • Government Medical College, Bhavnagar

    lead OTHER

Principal Investigators

  • Dr.Vishalkumar Kishorbhai Vadgama, M.B;B.S. · Department of Pharmacology, Government Medical College, Bhavnagar-364001, Gujarat, India

  • Dr. Chandrabhanu Rajkishore Tripathi, M.D. (Pharmacology) · Proffessor and Head, Department of Pharmacology, Government Medical College, Bhavnagar-364001, Gujarat, India

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01055470 on ClinicalTrials.gov